Citation: A. Pignone et al., Prostaglandin E-1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis, CLIN EXP RH, 19(3), 2001, pp. 358-359
Authors:
Simonini, G
Cerinic, MM
Cimaz, R
Anichini, M
Cesaretti, S
Zoppi, M
Generini, S
Falcini, F
Citation: G. Simonini et al., Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis, J RHEUMATOL, 28(1), 2001, pp. 198-203
Authors:
Simonini, G
Pignone, A
Generini, S
Falcini, F
Cerinic, MM
Citation: G. Simonini et al., Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis (vol 155, pg 1, 2000), TOXICOLOGY, 162(1), 2001, pp. 69-69
Authors:
Matucci-Cerinic, M
Giacomelli, R
Pignone, A
Cagnoni, ML
Generini, S
Casale, R
Cipriani, P
Del Rosso, A
Tirassa, P
Konttinen, YT
Kahaleh, BM
Fan, PS
Paoletti, M
Marchesi, C
Cagnoni, M
Aloe, L
Citation: M. Matucci-cerinic et al., Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma), ANN RHEUM D, 60(5), 2001, pp. 487-494
Authors:
Matucci-Cerinic, M
Pignone, A
Generini, S
Korn, JH
Citation: M. Matucci-cerinic et al., Can fibroblasts determine the late differing outcome between systemic sclerosis and primary hypertrophic osteoarthropathy (pachydermoperiostosis)?, CLIN EXP RH, 18(1), 2000, pp. 1-2
Authors:
Tuveri, M
Generini, S
Matucci-Cerinic, M
Aloe, L
Citation: M. Tuveri et al., NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis, LANCET, 356(9243), 2000, pp. 1739-1740
Authors:
Falcini, F
Azzari, C
Gelli, VAMG
Luchetti, M
Gabrielli, A
Calzolari, A
Pignone, A
Generini, S
Cerinic, MM
Citation: F. Falcini et al., Reduction of bcl-2 in T cells during immunosuppressive therapy in patientswith severe juvenile onset systemic lupus erythematosus, CLIN IMMUNO, 93(1), 1999, pp. 59-64
Authors:
Falcini, F
Generini, S
Pignone, A
Leoncini, G
Cimaz, R
Partsch, G
Matucci-Cerinic, M
Citation: F. Falcini et al., Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?, ENDOTHELIU, 6(3), 1999, pp. 209-215
Authors:
Cerinic, MM
Generini, S
Pignone, A
Cagnoni, M
Citation: Mm. Cerinic et al., From Raynaud's phenomenon to systemic sclerosis (scleroderma): Lack or exhaustion of adaptation?, ADV ORG BIO, 6, 1998, pp. 241-253